Finance ❯ Investments

Mergers and Acquisitions

Valuation Corporate Strategy Public Companies Pharmaceutical Industry Market Trends Market Analysis Yum Brands Market Opportunities Corporate Valuation Institutional Investors Venture Capital Airline Industry Asset Sale Takeover Bids Novartis Deal Structure Morgan Stanley Special Purpose Acquisition Companies International Investments TikTok Deal OnlyFans Sale Unicredit and Commerzbank Reverse Listings Fintech Corporate Finance Shareholder Value Electronic Arts WarnerMedia Acquisition Market Share Biopharma Valuation Google Stock Transactions Biotech Sector Crypto Companies Acquisitions Stake Purchases Biotech Companies Power Solutions Acquisition Performance-Based Payments Share Transactions Corporate Growth Crypto Exchanges Energy Sector DeFi Cash-and-Stock Deals Crypto Acquisitions Private Equity

BioMarin to Buy Alesta for $275 Million to Add Oral HPP Drug

Funded from cash on hand, the purchase brings ALE1 into BioMarin’s rare-skeletal portfolio, signaling a push to scale clinical-stage therapies.

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

Kraken Parent Seeks Judgment to Enforce $22 Million Award Against Former Auditor

MARA Strikes $1.5 Billion Deal for Ohio Power Plant to Drive AI Pivot

Dycom Posts Record Quarter and Year, Sets 2027 Outlook With Backlog at All-Time High

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Exodus to Acquire Uruguay’s Grateful to Expand Stablecoin Payments for Latin American Merchants

Longleaf Partners’ Q3 Letter: Fund Lags Benchmarks as Buybacks Drive Value Plan

NYDIG Urges Bitcoin Treasury Firms to Scrap mNAV After Strive–Semler Deal

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy